Literature DB >> 9952278

Breakdown of self-tolerance and the pathogenesis of autoimmunity.

G H Ring1, F G Lakkis.   

Abstract

Autoimmunity results from a breakdown of physiological mechanisms responsible for maintaining tolerance to self-antigens. These mechanisms are traditionally divided into central and peripheral. T or B lymphocytes that bind to self-antigens with high avidity are deleted or rendered unresponsive during their ontogeny in generative lymphoid organs such as the thymus and the bone marrow (central tolerance). However, this elimination process is incomplete, and regulatory mechanisms that keep mature autoreactive lymphocytes in check are necessary for preventing autoimmunity (peripheral tolerance). Peripheral tolerance mechanisms include passive or activation-induced T and B cell apoptosis, anergy, ignorance, and perhaps suppression of autoreactivity by regulatory lymphocytes. Observations in humans and experimental animals with defined genetic mutations provide examples of autoimmune disorders arising from failure to maintain peripheral tolerance to self. However, multiple factors are necessary for the induction of autoimmunity. For example, bacterial and viral infections may precipitate autoimmune disease in genetically susceptible individuals by exposing autoreactive T cells to cross-reactive peptides (molecular mimicry) or by enhancing lymphocyte stimulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9952278

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  11 in total

Review 1.  Modulating the immune system through nanotechnology.

Authors:  Tamara G Dacoba; Ana Olivera; Dolores Torres; José Crecente-Campo; María José Alonso
Journal:  Semin Immunol       Date:  2017-10-09       Impact factor: 11.130

Review 2.  Apoptosis and autoimmunity: complement deficiency and systemic lupus erythematosus revisited.

Authors:  J S Navratil; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2000-02       Impact factor: 4.592

3.  Characterizing a soluble survival signal for activated lymphocytes from CD14+ cells.

Authors:  Xiaolei Tang; David E Yocum; David DeJonghe; Kathy Nordensson
Journal:  Immunology       Date:  2002-09       Impact factor: 7.397

Review 4.  Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles.

Authors:  Fiona Y Glassman; Robert Dingman; Helena C Yau; Sathy V Balu-Iyer
Journal:  Immunol Invest       Date:  2020-03-23       Impact factor: 3.657

Review 5.  The Involvement of MicroRNAs in Modulation of Innate and Adaptive Immunity in Systemic Lupus Erythematosus and Lupus Nephritis.

Authors:  Mohsen Honarpisheh; Paulina Köhler; Ekaterina von Rauchhaupt; Maciej Lech
Journal:  J Immunol Res       Date:  2018-05-08       Impact factor: 4.818

Review 6.  Microbiome or Infections: Amyloid-Containing Biofilms as a Trigger for Complex Human Diseases.

Authors:  Amanda L Miller; Shingo Bessho; Kaitlyn Grando; Çagla Tükel
Journal:  Front Immunol       Date:  2021-02-26       Impact factor: 7.561

7.  Increased IgE serum levels are unrelated to allergic and parasitic diseases in patients with juvenile systemic lupus erythematosus.

Authors:  Bernadete L Liphaus; Adriana A Jesus; Clovis A Silva; Antonio Coutinho; Magda Carneiro-Sampaio
Journal:  Clinics (Sao Paulo)       Date:  2012-11       Impact factor: 2.365

8.  Elements of the B cell signalosome are differentially affected by mercury intoxication.

Authors:  Randall F Gill; Michael J McCabe; Allen J Rosenspire
Journal:  Autoimmune Dis       Date:  2014-05-04

Review 9.  Natural Products for the Treatment of Autoimmune Arthritis: Their Mechanisms of Action, Targeted Delivery, and Interplay with the Host Microbiome.

Authors:  Steven Dudics; David Langan; Rakeshchandra R Meka; Shivaprasad H Venkatesha; Brian M Berman; Chun-Tao Che; Kamal D Moudgil
Journal:  Int J Mol Sci       Date:  2018-08-24       Impact factor: 5.923

Review 10.  Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era.

Authors:  Leila Abdelhamid; Xin M Luo
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.